Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 262

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 262
---
 monthly contribution of up to $1,750 from us toward his healthcare premiums. In connection with entry into the Kucharchuk Employment Agreement, Mr. Kucharchuk has received certain equity awards under the Plan, the amount of such awards, vesting schedule and performance criteria are as set forth in the Kucharchuk Employment Agreement. The Kucharchuk Employment Agreement is for no specific period of time and either we or Mr. Kucharchuk may terminate the employment at any time and for any reason or no reason, with or without cause, and with or without notice. Consulting Agreement with Dr. Pierce On September 30, 2024, we entered into a consulting agreement with Kristen Pierce, Ph.D. (the “Pierce Consulting Agreement”), effective as of October 1, 2024. The Pierce Consulting Agreement has an initial term of twelve months, commencing October 1, 2024, as may be extended by mutual written agreement. Dr. Pierce will receive a monthly fee of $30,000 for her services during the term of the Pierce Consulting Agreement. In addition, Dr. Pierce received an award of 100 options to purchase shares of Common Stock, which will vest in equal monthly installments over twenty-four months, subject to Dr. Pierce’s continued service; provided, that the vesting of 50% such options shall be accelerated upon the FDA’s acceptance of our IND. Either party may terminate the Pierce Consulting Agreement at any time with at least 30 days’ prior written notice. On May 30, 2025, the board of directors granted Dr. Pierce options to purchase up to 7,742 shares of Common Stock, subject to vesting terms. 156 Outstanding Equity Awards as of December 31, 2024 The following table sets forth information regarding outstanding equity awards held by our named executive officers as of December 31, 2024:

| Name                           |     | Grant Date |     | Vesting      
 Commencement 
 Date         |     | Option Awards 
 Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Exercisable   |       |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Unexercisable |     |     | Option   
 Exercise 
 Price    
 ($)      |        |     | Option     
 Expiration 
 Date       |
|:-------------------------------|:----|:-----------|:----|:-------------|:----|:--------------|------:|